RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dont you shorts all cover at once ?This all confirms my hypothesis...thanks for the research. That first deal also closed on November 2st 2017, the SP on Nov. 2nd 2017 was about $17...still not over 50% of the deal price...definitely not what CRON is trading at compared to the buy in. Also, completely different time, the economics around weedstocks was so much less clear and this deal was a huge shock at the time and deserved a big run. Cronos has had it's same run...and again...as history has shown, even from both examples you provided...when dilution occurs (ESPECIALLY 45% OF THE COMPANY STOCK)....that the SP is never trading over 50% by that time. Just saying, you have proved my right and I will stick with my hypothesis.
rooo wrote: SOME more history lessons from 2017 for you below,, funny how time works its magic for those that wait ?? Don't worry it only hurts for a while when you cover ?? :The Constellation deal includes warrants that will let it eventually double its stake. The purchase is expected to close during the companys third fiscal quarter. Stock Rally Constellation is paying $12.98 a share, 1.5 per cent above Canopys closing price of $12.79 at the end of last week. Shares of the marijuana seller, which is based in an old Hershey chocolate factory in Smiths Falls, Ontario, have surged 40 per cent this year. We see this transaction as a game-changer for Canopy, as well as the industry at large, Beacon Securities analyst Vahan Ajamian said in a note. He recommends buying Canopy shares and raised his target price to $16.50 from $14. The Constellation transaction could be the first of many, Ajamian said. We suspect more alcohol companies may look to accelerate plans to enter the industry as well as pharmaceutical and tobacco companies, he said